Search

Michael Hellerstein Phones & Addresses

  • Valley Village, CA
  • 17424 Burbank Blvd, Encino, CA 91316 (818) 981-1061
  • 1991 Braeburn Cir, Atlanta, GA 30316 (404) 212-1855
  • 1785 Hummingbird Ln, Atlanta, GA 30307 (404) 254-3243
  • Oak Park, CA
  • Thousand Oaks, CA
  • East Liverpool, OH
  • Marietta, GA
  • Lynn, MA

Business Records

Name / Title
Company / Classification
Phones & Addresses
Michael Hellerstein
President
Hellerstein Consulting, LLC
Biotechnology · Business Consulting Services
1230 Peachtree St NE SUITE 2445, Atlanta, GA 30309
Michael Hellerstein
CFO
DRUID HILLS CIVIC ASSOCIATION, INC
Civic/Social Association · Membership Organization
Decatur, GA 30031
1785 Hummingbird Ln NE, Atlanta, GA 30307

Publications

Us Patents

Vectors Expressing Hiv Antigens And Gm-Csf And Related Methods Of Generating An Immune Response

View page
US Patent:
20130078276, Mar 28, 2013
Filed:
Feb 18, 2011
Appl. No.:
13/579667
Inventors:
Harriet L. Robinson - Atlanta GA, US
Rama R. Amara - Decatur GA, US
Michael Hellerstein - Atlanta GA, US
Lilin Lai - Decatur GA, US
International Classification:
C12N 15/85
US Classification:
4242081, 4353201, 536 235
Abstract:
The disclosure provides vectors encoding one or more HIV antigens and GM-CSF. Also provided are methods of inducing an immune response in a subject, methods of treating a subject having HIV, and methods of manufacturing a medicament for inducing an immune response that require the use of these vectors and vaccine inserts.

Vaccinia Viral Vectors Encoding Chimeric Virus Like Particles

View page
US Patent:
20230040403, Feb 9, 2023
Filed:
Jul 29, 2022
Appl. No.:
17/876682
Inventors:
- Smyrna GA, US
Arban Domi - Atlanta GA, US
Michael Hellerstein - Marietta GA, US
Farshad Guirakhoo - Atlanta GA, US
Nathanael Paul McCurley - Decatur GA, US
Assignee:
GeoVax, Inc. - Smyrna GA
International Classification:
A61K 39/00
C12N 15/86
Abstract:
The compositions and methods are described for generating an immune response to an antigen. The compositions and methods described herein relate to a modified vaccinia Ankara (MVA) vector encoding one or more viral antigens as a fusion product with a viral glycoprotein and matrix protein for generating a protective immune response to a subject to which the vector is administered. The compositions and methods of the present invention are useful both prophylactically and therapeutically and may be used to prevent and/or treat diseases.

Vaccinia Viral Vectors Encoding Chimeric Virus Like Particles

View page
US Patent:
20200289633, Sep 17, 2020
Filed:
Feb 20, 2020
Appl. No.:
16/796350
Inventors:
- Smyrna GA, US
Arban Domi - Atlanta GA, US
Michael Hellerstein - Marietta GA, US
Farshad Guirakhoo - Atlanta GA, US
Nathanael Paul McCurley - Decatur GA, US
Assignee:
GeoVax, Inc. - Smyrna GA
International Classification:
A61K 39/00
C12N 15/86
Abstract:
The compositions and methods are described for generating an immune response to an antigen. The compositions and methods described herein relate to a modified vaccinia Ankara (MVA) vector encoding one or more viral antigens as a fusion product with a viral glycoprotein and matrix protein for generating a protective immune response to a subject to which the vector is administered. The compositions and methods of the present invention are useful both prophylactically and therapeutically and may be used to prevent and/or treat diseases

Compositions And Methods For Generating An Immune Response To A Tumor Associated Antigen

View page
US Patent:
20190290745, Sep 26, 2019
Filed:
Jan 9, 2017
Appl. No.:
16/068527
Inventors:
- Smyma GA, US
Arban Domi - Atlanta GA, US
Michael Hellerstein - Marietta GA, US
Farshad Guirakhoo - Atlanta GA, US
Nathanael Paul McCurley - Decatur GA, US
International Classification:
A61K 39/00
C12N 15/86
Abstract:
The compositions and methods are described for generating an immune response to a tumor associated antigen such as MUC1. The compositions and methods described herein relate to a modified vaccinia Ankara (MVA) vector encoding one or more viral antigens for generating a protective immune response to a neoplasm expressing the tumor associated antigen in the subject to which the vector is administered. The compositions and methods of the present invention are useful both prophylactically and therapeutically and may be used to prevent and/or treat neoplasms and associated diseases.
Michael A Hellerstein from Valley Village, CA, age ~42 Get Report